Filing Details

Accession Number:
0001127602-14-018547
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-22 17:57:33
Reporting Period:
2014-05-21
Filing Date:
2014-05-22
Accepted Time:
2014-05-22 17:57:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1022079 Quest Diagnostics Inc DGX Services-Medical Laboratories (8071) 161387862
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1222674 B John Ziegler C/O Quest Diagnostics Incorporated
3 Giralda Farms
Madison NJ 07940
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-05-21 2,924 $0.00 18,800 No 4 A Direct
Common Stock Acquisiton 2014-05-22 998 $47.94 19,798 No 4 M Direct
Common Stock Disposition 2014-05-22 998 $57.66 18,800 No 4 S Direct
Common Stock Disposition 2014-05-22 1,975 $57.65 16,825 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2014-05-22 998 $0.00 998 $47.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2005-01-01 2015-01-01 No 4 M Direct
Footnotes
  1. Represents an award of restricted share units.
  2. This transaction was executed in multiple trades at prices ranging from $57.6600 to $57.6653. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $57.6452 to $57.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.